EXTEDO Blog (11) | EXTEDO

The Chinese Food & Drug Administration moves to eCTD

EMA Officially Endorses the New EudraVigilance System for Adverse Reactions

Why we believe in IDMP, and you should too

EXTEDO Opens New Office in Shanghai

EXTEDO上海分公司成立！

Health Canada confirms mandatory use of eCTD format from 1st January 2018

eRA 2017 - A first-timers impressions

New Requirements for Electronic Submission of Drug Master Files (DMFs)

eSubmissions in South America

The impact of mandatory reporting of non-serious cases in EudraVigilance

The Business & Pharmacovigilance Impact of E2B(R3)

Introduction to E2B(R3)

First Prev11 / 13Next Last